PTC Therapeutics (NASDAQ:PTCT) Announces Quarterly Earnings Results, Beats Expectations By $1.39 EPS

PTC Therapeutics (NASDAQ:PTCT - Get Free Report) released its earnings results on Tuesday. The biopharmaceutical company reported $0.20 earnings per share for the quarter, topping the consensus estimate of ($1.11) by $1.31. PTC Therapeutics had a net margin of 35.65% and a negative return on equity of 106.31%.